Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01037569 · ClinicalTrials.gov registry record
Optimizing Toxicological Screening in Drug Endangered Children
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 100
- Enrollment target
NCT01037569 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 100 participants.
The verdict
NCT01037569 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Background: * Children who enter the foster care system are all too often exposed to illicit drugs in the home. Children from these homes, known as drug endangered children, are not routinely tested for harmful substances. Any short- and long-term physical or developmental problems they may experience as a result of this exposure often go undetected and untreated. * Children who are placed into protective custody are not always screened by physicians or nurse practitioners. Although drug-endangered children under 18 years of age automatically receive a urine toxicology screen to determine the types and levels of illicit drugs in their systems, this procedure has difficulties and limitations that may affect the quality of the data. Researchers are interested in developing more effective methods of analyzing the presence or absence of illicit environmental drug exposure in children. Objectives: \- To determine the most effective method of identifying long-term illicit stimulant drug exposure in drug-endangered children. Eligibility: \- Children under 18 years of age who are being placed into protective custody after having been found in a home where drugs are manufactured, used, or sold. Design: * Researchers will gain verbal consent for the procedure for children who are 7 years of age or older. Children younger than 7 years of age will not be required to give verbal consent for sample collection. * Researchers will collect standard urine samples for toxicological screening. Part of the sample will be sent to the National Institute on Drug Abuse for evaluation; the rest will remain with the local authority. * In addition to this standard procedure, researchers will collect a hair sample by cutting a small amount of hair from the crown of the head as close to the root as possible (and not pulling any hair out of the child's head). * Researchers will also use an oral swab to collect a saliva sample from the inside cheek of each child. * No clinical care will be
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2007-07-10 |
| Est. Completion | 2011-03-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01037569
The ClinicalTrials.gov registry entry for NCT01037569 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01037569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01037569 about?
NCT01037569 is a clinical study titled "Optimizing Toxicological Screening in Drug Endangered Children". Background: * Children who enter the foster care system are all too often exposed to illicit drugs in the home. Children from these homes, known as drug endangered children, are not routinely tested for harmful substances. Any short- and long-term physical or developmental problems they may experie...
What is the current status of trial NCT01037569?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2007-07-10. Estimated completion is 2011-03-22.
Who is sponsoring clinical trial NCT01037569?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.